Eiasi Expands In US

North America has became Japanese drugmaker Eisai 's largest market last year with sales reaching JPY303.4bn (US$2.5bn), around 45% of total turnover. The strong performance was driven by surging demand for leading products such as Alzheimer's drug Aricept (donepezil) and ulcer treatment Aciphex (rabeprazole).

To read the full article, please choose one of the following options: